Company Filing History:
Years Active: 2023-2024
Title: Innovator in Pulmonary Fibrosis Treatment: Futwan Al-Mohanna
Introduction
Futwan Al-Mohanna is an esteemed inventor and researcher located in Riyadh, Saudi Arabia. He specializes in the development of innovative methods for diagnosing and treating pulmonary diseases. With a strong focus on the S100 proteins, his groundbreaking work has resulted in multiple patents aimed at combating pulmonary fibrosis.
Latest Patents
Futwan Al-Mohanna holds three patents, with his latest innovations being pivotal in the medical field.
1. **Method for treating pulmonary fibrosis using S100A3 protein** - This invention focuses on a novel method for diagnosing and treating pulmonary lung disease by detecting a mutant S100A3 protein associated with the condition. The approach includes treating subjects with a functional S100A3 protein, providing a potential breakthrough in therapy for affected patients.
2. **Method for diagnosing or treating pulmonary fibrosis using S100A13 protein** - This patent extends his work to include another critical protein. It details a method for diagnosing and treating pulmonary fibrosis linked to mutations in the S100A13 and S100A3 genes. The invention discloses methods for detecting these gene mutations and offers strategies to compensate for the functional losses caused by the aberrant proteins.
Career Highlights
Futwan Al-Mohanna currently works at the King Faisal Specialist Hospital & Research Centre, where he contributes to advancing medical research and innovation in pulmonary health. His dedication to merging clinical practices with research has established him as a notable figure in his field.
Collaborations
Throughout his career, Futwan has had the privilege of collaborating with skilled professionals such as Eid Abdullah Al Mutairy and Mohammed Khalid. Their joint efforts facilitate significant advancements in research and treatment methodologies, fostering a collaborative spirit within the medical community.
Conclusion
Futwan Al-Mohanna's contributions to the field of pulmonary fibrosis research showcase his commitment to innovation and patient care. With his patents paving the way for advancements in diagnosis and treatment, he continues to inspire future innovators in the healthcare domain.